1

Rotavirus Vaccine Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 250

CHAPTER 1. Industry Overview of Rotavirus Vaccine Market

1.1. Definition and Scope 

1.1.1. Definition of Rotavirus Vaccine

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Rotavirus Vaccine Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Rotavirus Vaccine Market By Type

1.2.3. Rotavirus Vaccine Market By End-Use

1.2.4. Rotavirus Vaccine Market By Regions

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Rotavirus Vaccine Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Rotavirus Vaccine Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Cost Structure Analysis

3.9.1. Price Trend of Key Raw Materials

3.9.2. Raw Material Suppliers

3.9.3. Proportion of Manufacturing Cost Structure

3.9.3.1. Raw Material Cost

3.9.3.2. Labor Cost

3.9.3.3. Manufacturing Expense

3.10. Competitive Landscape, 2021

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021

4.2. R&D Status of Major Manufacturers in 2021

CHAPTER 5. Rotavirus Vaccine Market Revenue By Type

5.1. Introduction

5.2. Rotavirus Vaccine Market Revenue (USD Million) By Type

5.2.1. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

5.2.2. Lanzhou Lamb

5.2.2.1. Lanzhou Lamb Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3. Rotarix

5.2.3.1. Rotarix Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.4. Rotavac

5.2.4.1. Rotavac Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.5. Rotavin-M1

5.2.5.1. Rotavin-M1 Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.6. Others

5.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 6. Rotavirus Vaccine Market Revenue By End-Use

6.1. Introduction

6.2. Rotavirus Vaccine Market Revenue (USD Million) By End-Use

6.2.1. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

6.2.2. Hospitals

6.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.3. Clinics

6.2.3.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.4. Academic & Research Lab

6.2.4.1. Academic & Research Lab Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 7. North America Rotavirus Vaccine Market By Country 

7.1. North America Rotavirus Vaccine Market Overview

7.2. U.S.

7.2.1. U.S. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

7.2.2. U.S. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

7.3. Canada

7.3.1. Canada Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

7.3.2. Canada Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

7.4. North America PEST Analysis

CHAPTER 8. Europe Rotavirus Vaccine Market By Country

8.1. Europe Rotavirus Vaccine Market Overview

8.2. U.K.

8.2.1. U.K. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

8.2.2. U.K. Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.3. Germany

8.3.1. Germany Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

8.3.2. Germany Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.4. France

8.4.1. France Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

8.4.2. France Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.5. Spain

8.5.1. Spain Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

8.5.2. Spain Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.6. Rest of Europe

8.6.1. Rest of Europe Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

8.6.2. Rest of Europe Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.7. Europe PEST Analysis

CHAPTER 9. Asia-Pacific Rotavirus Vaccine Market By Country

9.1. Asia-Pacific Rotavirus Vaccine Market Overview

9.2. China

9.2.1. China Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

9.2.2. China Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.3. Japan

9.3.1. Japan Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

9.3.2. Japan Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.4. India

9.4.1. India Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

9.4.2. India Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.5. Australia

9.5.1. Australia Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

9.5.2. Australia Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.6. South Korea

9.6.1. South Korea Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

9.6.2. South Korea Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

9.7.2. Rest of Asia-Pacific Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Rotavirus Vaccine Market By Country

10.1. Latin America Rotavirus Vaccine Market Overview

10.2. Brazil

10.2.1. Brazil Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

10.2.2. Brazil Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

10.3. Mexico

10.3.1. Mexico Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

10.3.2. Mexico Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

10.4. Rest of Latin America

10.4.1. Rest of Latin America Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

10.4.2. Rest of Latin America Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Rotavirus Vaccine Market By Country 

11.1. Middle East & Africa Rotavirus Vaccine Market Overview

11.2. GCC

11.2.1. GCC Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

11.2.2. GCC Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

11.3. South Africa

11.3.1. South Africa Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

11.3.2. South Africa Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Rotavirus Vaccine Market Revenue (USD Million) and Forecast By Type, 2018-2030

11.4.2. Rest of Middle East & Africa Rotavirus Vaccine Market Revenue (USD Million) and Forecast By End-Use, 2018-2030

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Rotavirus Vaccine Market

12.1. Rotavirus Vaccine Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of Key Players by Price, Presence, Market Share, and R&D Investment

12.2.2. Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Rotavirus Vaccine Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. BIOVIRx Inc

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Market Revenue (USD Million), 2021

13.1.3.2. BIOVIRx Inc 2021 Rotavirus Vaccine Business Regional Distribution

13.1.4. Product/service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. Serum Institute of India Pvt. Ltd.

13.3. Merck & Co., Inc.

13.4. Bharat Biotech

13.5. Biological E

13.6. Bio Farma

13.7. Novartis AG

13.8. GlaxoSmithKline plc.

13.9. Sanofi

13.10. Lanzhou Institute of Biologicals Products Co., Ltd

13.11. Berghofer Medical Research Institute

13.12. Pfizer, Inc.

Cart Summary